 will helm the investigation after it was alerted that three people experienced worrying side effects from the weight loss jabs that have taken the world by storm. 1 A small number of users have reported suicidal thoughts and behaviours while taking the appetite suppressing drugs Iceland - who is a member state of the European drugs regulator - brought the three cases to the agency's attention. Product leaflets for the prescription drugs already include suicidal thoughts in their list of possible side effects, but not suicidal behaviour. The EMA's Pharmacovigilance Risk Assessment Committee (PRAC) is set to assess the risks of using medication that contains semaglutide - the main ingredient in Wegovy and Ozempic - or liraglutide, which Saxenda is made up of, the BBC reported. But it will also consider whether similar treatments that use glucagon-like peptide-1 technology (GLP-1) to regulate appetite also need assessing. An EMA official told the BBC it was carrying out the review after receiving what is called a 'signal procedure' from Icelandic Medicines Agency, following three case reports. They explained: "A signal is information on a new or known adverse event that is potentially caused by a medicine and that warrants further investigation. "The case reports included two cases of suicidal thoughts - one following the use of Saxenda and one after Ozempic. "One additional case reported thoughts of self-injury with Saxenda. The official said the EMA would share more information once it was able to do so. Novo Nordisk, the manufacturer of the drugs, told the BBC it was working with the EMA on the investigation and that patient safety is a top priority. A representative said: "GLP-1 receptor agonists have been used to treat type-2 diabetes for more than 15 years an){kind=link}
APPETITE curbing jabs Wegovy, Saxenda and Ozempic are set to undergo a safety review following reports of a possible link to thoughts of suicide and self-harm among users.
The European Medicines Agency (EMA) will helm the investigation after it was alerted that three people experienced worrying side effects from the weight loss jabs that have taken the world by storm.
Iceland – who is a member state of the European drugs regulator – brought the three cases to the agency’s attention.
Product leaflets for the prescription drugs already include suicidal thoughts in their list of possible side effects, but not suicidal behaviour.
The EMA’s Pharmacovigilance Risk Assessment Committee (PRAC) is set to assess the risks of using medication that contains semaglutide – the main ingredient in Wegovy and Ozempic – or liraglutide, which Saxenda is made up of, the BBC reported.